Study to Evaluate the Preference, Satisfaction and Correct Use of Inhalers in Patients With Chronic Obstructive Pulmonary Disease
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2017
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms INHALATOR
- Sponsors Novartis Pharmaceuticals
- 02 Mar 2016 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 19 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Apr 2015, according to ClinicalTrials.gov record.
- 19 Jan 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Apr 2015, according to ClinicalTrials.gov record.